Clinical Research

Results of multiple clinical studies have demonstrated that VAX-D is an effective treatment for the management of chronic low back pain. A retrospective outcome study on 778 patients, a Phase II Randomized Controlled Trial and a study conducted in a neurosurgery practice on the number of treatments for success, all reported approximately 70% success rates and improvements in functional outcomes for patients suffering from disc related chronic back pain.

A two-year study sponsored by Independence Blue Cross has just been released in 2008. The purpose was to determine short- and long-term outcomes after VAX-D treatment in a large sample of patients with activity-limiting low back pain that had failed at least two previous, non-surgical treatments.  The study showed that patients had significantly improved pain and disability scores at the end of treatment, at 30 days and at 180 days post-discharge.

In addition, several research articles have been published examining the mechanism of action of VAX-D.  Studies on the effects of VAX-D on intradiscal pressures have been reported, and it’s effects on sensory nerve dysfunction in patients with low back pain and radiculopathy have been published.

Dermatomal Somatosensory Evoked Potentials (DSSEP’s) were used to demonstrate lumbar nerve root decompression following VAX-D Therapy.

VAX-D Medical Technologies has been at the forefront of research in spinal pain (low back and cervical pathology).  VAX-D has had a long history of peer reviewed clinical studies published on different aspects of the treatment. The VAX-D system is being utilized by physicians in Orthopedic Medicine, Pain Management, Anesthesiology, Occupational Medicine and Rehabilitation, Neurology, Neurosurgery, Family Practice and Chiropractic.  Research on the therapy is ongoing and VAX-D Medical Technologies will post future publications on this website as they become available.

The Genesis Cervical treatment technology has been in development and testing for over ten years.  Advances in software and electronic ‘biofeedback’ in the last two years have provided the means for programming treatment curves in two planes of motion.

Cervical traction is typically applied with a halter or harness/slide mechanism with the head and neck in some degree of flexion. Available treatments include the use of tensions in the 25-50 lb range; the use of an angle of 15° to 20° of flexion for all clinical indications; treatment time of 10 minutes; and linear (straight-line) modes of either static or intermittent tension.  We found that none of these standard protocols were effective for treating chronic cervical disc pathology.

The Genesis technology and protocols have truly revolutionized cervical treatment.  The combination of applying tension in a logarithmic time/force curve, and establishing the optimal ‘arc’ of the tension source is designed to  bypass the ‘lock-down’ muscle guarding in the cervical spine.  Patients are able to really relax the head and neck muscles during treatment, while the tension reduces the load on the spine. Most patients may now be treated within a range of 10-22 lbs of tension, each with their own programmed ‘dynamic arc’.  

The Future’s Technology – Here Now